Neurocrine Biosciences Inc (NBIX)
132.04
-0.50
(-0.38%)
USD |
NASDAQ |
Apr 19, 16:00
132.00
-0.04
(-0.03%)
After-Hours: 20:00
Neurocrine Biosciences Cash from Operations (TTM): 389.90M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 389.90M |
| September 30, 2023 | 409.40M |
| June 30, 2023 | 296.20M |
| March 31, 2023 | 254.70M |
| December 31, 2022 | 339.40M |
| September 30, 2022 | 200.60M |
| June 30, 2022 | 163.60M |
| March 31, 2022 | 128.70M |
| December 31, 2021 | 256.50M |
| September 30, 2021 | 346.80M |
| June 30, 2021 | 264.60M |
| March 31, 2021 | 280.30M |
| December 31, 2020 | 228.50M |
| September 30, 2020 | 231.50M |
| June 30, 2020 | 349.70M |
| March 31, 2020 | 295.00M |
| December 31, 2019 | 147.00M |
| September 30, 2019 | 99.99M |
| June 30, 2019 | 71.11M |
| March 31, 2019 | 27.39M |
| December 31, 2018 | 101.40M |
| September 30, 2018 | 91.48M |
| June 30, 2018 | 13.26M |
| March 31, 2018 | -55.46M |
| December 31, 2017 | -94.33M |
| Date | Value |
|---|---|
| September 30, 2017 | -166.53M |
| June 30, 2017 | -188.23M |
| March 31, 2017 | -154.33M |
| December 31, 2016 | -106.18M |
| September 30, 2016 | -89.76M |
| June 30, 2016 | -77.32M |
| March 31, 2016 | -49.02M |
| December 31, 2015 | -38.00M |
| September 30, 2015 | -38.10M |
| June 30, 2015 | -31.63M |
| March 31, 2015 | -55.56M |
| December 31, 2014 | -47.14M |
| September 30, 2014 | -42.71M |
| June 30, 2014 | -41.39M |
| March 31, 2014 | -41.29M |
| December 31, 2013 | -29.61M |
| September 30, 2013 | -27.64M |
| June 30, 2013 | -25.16M |
| March 31, 2013 | -22.18M |
| December 31, 2012 | -35.29M |
| September 30, 2012 | -15.36M |
| June 30, 2012 | -4.29M |
| March 31, 2012 | -3.322M |
| December 31, 2011 | -0.698M |
| September 30, 2011 | -16.25M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
71.11M
Minimum
Jun 2019
409.40M
Maximum
Sep 2023
250.18M
Average
256.50M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| Globus Medical Inc | 243.50M |
| Inspire Medical Systems Inc | 24.65M |
| AIM ImmunoTech Inc | -21.27M |
| Protalix BioTherapeutics Inc | -1.318M |
| Armata Pharmaceuticals Inc | -47.42M |